A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

NCT03070990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Urothelial Cancer

Interventions

DRUG: Enfortumab vedotin

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]